Prevalence of hand dysfunction in cerebral palsy following botulinum toxin therapy

被引:0
|
作者
Alahmar-Bianchin, M. [1 ]
Saraiva-Storti, H. C. [1 ]
Fornari-Chueire, R. [1 ]
Lucato, R. V., Jr. [1 ]
机构
[1] Fac Med, BR-15090040 Sao Jose do Rio Preto, SP, Brazil
关键词
botulinum toxin; cerebral palsy; functional independence; hand functioning; occupational therapy; proprioception;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim. To examine the level of dependence, the functional class, the most frequent type of compromise and the proprioception of the hand in spastic cerebral palsy following the application of botulinum toxin, as well as to determine the socio-demographic characteristics of the individuals involved. Patients and methods. We conducted a cross-sectional study of 21 spastic patients with extrinsic muscle involvement, of both sexes and a mean age of 15.4 +/- 5.6 years, who attended the neuro-rehabilitation outpatients department and were treated with botulinum toxin in the muscles responsible for the functional movements in the hand; they were evaluated after a mean period of 2.1 years. Patients were subjected to procedures such as a semi-structured interview, the FIM (Functional Independence Measurement) scale, Hausen's functional characterisation, Zancolli classification and a proprioception test. Results. There was a predominance of females (57% of patients) and of a basic level of schooling. On the FIM scale, 38% of the patients presented modified independence, without help; 23.8% belonged to Hansen grade 3 (grasping and holding an object steady with the help of the other hand). On the Zancolli classification, 54% belonged to type III (the fingers can only be extended if the fist is bent more than 70 degrees); perception of movement is absent (76.2%) and the sense of position of the movement is altered (54.2%). Conclusions. Findings confirmed the existence of a high rate of modified independence, grade 3 (Hausen), together with type III involvement (Zancolli) and alterations affecting proprioception. Data from the study show the importance of occupational therapy as part of the care received by patients with cerebral palsy following the administration of botulinum toxin type A.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 50 条
  • [41] Influence of Botulinum Toxin Therapy on Postural Control and Lower Limb Intersegmental Coordination in Children with Spastic Cerebral Palsy
    Degelaen, Marc
    de Borre, Ludo
    Kerckhofs, Eric
    de Meirleir, Linda
    Buyl, Ronald
    Cheron, Guy
    Dan, Bernard
    TOXINS, 2013, 5 (01): : 93 - 105
  • [42] Effectiveness of botulinum toxin type a in cerebral palsy: Low dose or high dose?
    Dai, Alper I.
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2006, 13 (03) : 147 - 150
  • [43] The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy
    Heinen, Florian
    Desloovere, Kaat
    Schroeder, A. Sebastian
    Berweck, Steffen
    Borggraefe, Ingo
    van Campenhout, Anya
    Andersen, Guro L.
    Aydin, Resa
    Becher, Jules G.
    Bernert, Guenther
    Martinez Caballero, Ignacio
    Carr, Lucinda
    Valayer, Emmanuelle Chaleat
    Desiato, Maria Teresa
    Fairhurst, Charlie
    Filipetti, Paul
    Hassink, Ralph-Ingo
    Hustedt, Ulf
    Jozwiak, Marek
    Kocer, Serdar Ibrahim
    Kolanowski, Elisabeth
    Kraegeloh-Mann, Ingeborg
    Kutlay, Sehim
    Maenpaa, Helena
    Mall, Volker
    McArthur, Paul
    Morel, Edith
    Papavassiliou, Antigone
    Pascual-Pascual, Ignacio
    Pedersen, Soren Anker
    Plasschaert, Frank S.
    van der Ploeg, Irene
    Remy-Neris, Olivier
    Renders, Anne
    Di Rosa, Guiseppe
    Steinlin, Maja
    Tedroff, Kristina
    Vidal Valls, Joan
    Viehweger, Elke
    Molenaers, Guy
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2010, 14 (01) : 45 - 66
  • [44] Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences
    Lorin, K.
    Forsberg, A.
    CHILD CARE HEALTH AND DEVELOPMENT, 2016, 42 (04) : 494 - 503
  • [45] MUSCLE HISTOPATHOLOGY IN CHILDREN WITH SPASTIC CEREBRAL PALSY RECEIVING BOTULINUM TOXIN TYPE A
    Valentine, Jane
    Stannage, Katherine
    Fabian, Vicki
    Ellis, Kevin
    Reid, Siobhan
    Pitcher, Christian
    Elliott, Catherine
    MUSCLE & NERVE, 2016, 53 (03) : 407 - 414
  • [46] Botulinum toxin for postoperative care after limb surgery in cerebral palsy children
    Dohin, B.
    Garin, C.
    Vanhems, P.
    Kohler, R.
    REVUE DE CHIRURGIE ORTHOPEDIQUE ET REPARATRICE DE L APPAREIL MOTEUR, 2007, 93 (07): : 674 - 681
  • [47] Botulinum toxin type A in subjects with spastic cerebral palsy from Eastern India
    Misra, Amar Kumar
    Kumar, Sanjay
    Biswas, Arup
    Das, Shyamal Kumar
    JOURNAL OF PEDIATRIC NEUROLOGY, 2010, 8 (04) : 349 - 357
  • [48] USE AND ADVERSE EFFECTS OF BOTULINUM TOXIN IN MANAGEMENT OF CHILDREN WITH SPASTIC CEREBRAL PALSY
    Ulici, Alexandru
    Sterian, Alin-Gabriel
    Tevanov, Iulia
    Popescu, Mihai-Bogdan
    FARMACIA, 2017, 65 (03) : 454 - 459
  • [49] Botulinum Toxin A Treatment in Spastic Forms of Cerebral Palsy: A Retrospective Clinical Study
    Fujak, A.
    Koeckeritz, S.
    Haeberle, L.
    Desman, C.
    Lorenz, I.
    Koeckeritz, J.
    Forst, R.
    Forst, J.
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2012, 150 (02): : 181 - 189
  • [50] A complete functional instrumental assessment for botulinum toxin injection in cerebral palsy (CP)
    Turconi, AC
    Piccinini, L
    Motta, F
    Stefanoni, G
    Salandi, A
    Maghini, C
    Bresolin, N
    SAGGI-NEUROPSICOLOGIA INFANTILE PSICOPEDAGOGIA RIABILITAZIONE, 1998, 24 (02): : 67 - 73